The purpose of this cooperative agreement is to establish an information-sharing system and conduct research on the information obtained by this system to improve the information available to state regulators and FDA about compounding pharmacies that distribute interstate and support better and more
credit:
targeted regulation and oversight to reduce risk to patients.
In part, this system will facilitate state information reporting to FDA under future agreements between the states and FDA addressing interstate distribution of compounded drugs.